Attached hereto as Exhibit 99.1 is a transcript of a conference call that Transcept Pharmaceuticals, Inc. conducted at 8:30 am Eastern time on October 29, 2009 and made available to the public by telephone and through webcast accessible through its website at such time. Exhibit 99.1 is incorporated herein by reference.

The information in this Form 8-K and the Exhibit attached hereto shall not be deemed "filed" for the purposes of Section 18 of the Securities Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liabilities of that Section, or incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such filing. The furnishing of the attached information is not an admission as to the materiality of any of the information set forth therein.

(d) Exhibits.

Exhibit No.       Description

99.1              Transcript of Transcept Pharmaceuticals, Inc. conference call
                  held on October 29, 2009.